{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":1,"sponsored":0,"items":[{"id":"n_qrx2sayyue7lnxo5y23a","seq":1064625,"kind":"article","title":"F. Hoffmann-La Roche Ltd: Roche's giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine","url":"https://www.finanznachrichten.de/nachrichten-2026-10/69724812-f-hoffmann-la-roche-ltd-roche-s-giredestrant-combination-significantly-improved-progression-free-survival-in-er-positive-advanced-breast-cancer-in-p-399.htm","published":"2026-10-01T06:13:31Z","seen":"2026-10-01T06:13:31Z","lang":"en","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","business","science","health"],"authors":["GlobeNewswire (Europe)"],"entities":[{"id":"Q131882228","name":"F. Hoffmann-La Roche Ltd","type":"org"},{"id":"Q2160232","name":"Roche","type":"org"},{"id":"Q582728","name":"The New England Journal of Medicine","type":"org"}],"story":"st_xh67iaelhosqksymdknq","category":"health","category_p":0.73,"sentiment":"positive","tone":-0.13,"political":0.03}]}